Serum mucosal chemokine levels in patients with Parkinson disease.
Objective: To investigate the relationship between mucosal chemokines including CXCL14 and CCL28) and impairment in motor/non-motor function among patients with Parkinson’s disease. Background: Parkinson disease…APOmorphine infusion and aMYLoid deposition in Parkinson’s disease (APOMYL): preliminary clinical and amyloid imaging data
Objective: To explore the potential effects of chronic Apomorphine infusion treatment on reducing brain Amyloid-b (Aβ) deposition in Parkinson’s disease (PD). Background: A majority of…Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full
Objective: To describe the cognitive-psychiatric course in the first 5 years of diagnosed Parkinson disease (PD). Background: Although common, little is known about the differential…Clinical and neuroimaging heterogeneity of dementia with Lewy bodies
Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease
Objective: The Seoul-instrumental activity of daily living (S-iADL) scale is well known to the tool for instrumental activities of Korean elders. However, the cutoff point…Pisa syndrome in Parkinson’s disease: a study on the neuropsychological profile.
Objective: To evaluate whether Pisa syndrome (PS) in Parkinson’s disease (PD) is associated with a specific profile of cognitive impairment. Background: PS is a complex…Cognitive impairment in Parkinson’s Disease: A cross-sectional association study
Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors…Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)
Objective: To assess the value of motor (MS), non-motor symptoms (NMS), HAQL and activities of daily living (ADL) for predicting mortality in PD. Background: Parkinson’s…Association of MRI-derived estimated brain age and cognitive ability in Parkinson’s disease
Objective: To characterise MRI-derived structural age-related brain health in Parkinson’s disease (PD) patients as a function of cognitive ability. Background: Normal ageing produces a stereotypical…Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database
Objective: This study characterises the comorbidities and symptoms, and treatment patterns of patients with Huntington’s disease (HD) vs patients with Parkinson’s disease (PD) vs the…
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 128
- Next Page »